Cabaletta Bio (CABA) Other Working Capital Changes (2018 - 2025)
Cabaletta Bio's quarterly Other Working Capital Changes came in at -$1.1 million in Q4 2025, up 58.6% year-on-year from -$666466.0 in Q4 2024, and up 74.73% quarter-over-quarter from -$4.2 million in Q3 2025.
Cabaletta Bio has reported Other Working Capital Changes for 8 years, with the latest figure at -$1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 58.6% year-over-year to -$1.1 million; the trailing twelve-month figure through Dec 2025 stood at -$4.2 million (down 28.44% YoY), and the FY2025 full-year result was -$4.2 million, down 28.44% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$1.1 million, up from -$4.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.7 million in Q3 2021, with the low at -$4.2 million in Q3 2025.
- Average Other Working Capital Changes over 5 years is -$461300.0, with a median of -$190000.0 recorded in 2022.
- Year-over-year, Other Working Capital Changes sank 8918.18% in 2022 and jumped 394.0% in 2024.
- Tracing CABA's Other Working Capital Changes over 5 years: stood at $33000.0 in 2021, then slumped by 8918.18% to -$2.9 million in 2022, then surged by 124.88% to $724000.0 in 2023, then tumbled by 452.62% to -$2.6 million in 2024, then surged by 58.6% to -$1.1 million in 2025.
- The last three Other Working Capital Changes figures came in at -$1.1 million (Q4 2025), -$4.2 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -4.18 Mn |
| Sep 30, 2025 | -4.18 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | -968,000.00 |
| Jun 30, 2024 | -968,000.00 |
| Mar 31, 2024 | -1.25 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | 724,000.00 |
| Dec 31, 2023 | 724,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | -2.91 Mn |
| Dec 31, 2022 | -2.91 Mn |
| Sep 30, 2022 | 380,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | -287,000.00 |
| Jun 30, 2022 | -287,000.00 |
| Mar 31, 2022 | -93,000.00 |
| Mar 31, 2022 | -93,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Sep 30, 2021 | 2.69 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | -1.52 Mn |
| Jun 30, 2021 | -1.52 Mn |
| Mar 31, 2021 | -1.15 Mn |
| Mar 31, 2021 | -1.15 Mn |
| Dec 31, 2020 | 60,000.00 |
| Dec 31, 2020 | 60,000.00 |
| Sep 30, 2020 | 810,000.00 |
| Sep 30, 2020 | 810,000.00 |
| Jun 30, 2020 | 558,000.00 |
| Jun 30, 2020 | 558,000.00 |
| Mar 31, 2020 | -1.23 Mn |
| Mar 31, 2020 | -1.23 Mn |
| Dec 31, 2019 | 10,000.00 |
| Dec 31, 2019 | 10,000.00 |
| Sep 30, 2019 | 184,000.00 |
| Sep 30, 2019 | 184,000.00 |
| Jun 30, 2019 | 656,000.00 |
| Jun 30, 2019 | 656,000.00 |
| Mar 31, 2019 | -749,000.00 |
| Mar 31, 2019 | -749,000.00 |
| Dec 31, 2018 | 757,000.00 |
| Dec 31, 2018 | 757,000.00 |